Literature DB >> 23572487

Effects of smoking on non-AIDS-related morbidity in HIV-infected patients.

Daniel K Shirley1, Robert J Kaner, Marshall J Glesby.   

Abstract

Tobacco smoking has many adverse health consequences. Patients with human immunodeficiency virus (HIV) infection smoke at very high rates, and many of the comorbidities associated with smoking in the general population are more prevalent in this population. It is likely that a combination of higher smoking rates along with an altered response to cigarette smoke throughout the body in persons with HIV infection leads to increased rates of the known conditions related to smoking. Several AIDS-defining conditions associated with smoking have been reviewed elsewhere. This review aims to summarize the data on non-AIDS-related health consequences of smoking in the HIV-infected population and explore evidence for the potential compounding effects on chronic systemic inflammation due to HIV infection and smoking.

Entities:  

Keywords:  HIV; comorbidity; smoking; tobacco

Mesh:

Year:  2013        PMID: 23572487      PMCID: PMC3689343          DOI: 10.1093/cid/cit207

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  103 in total

Review 1.  Periodontal diseases.

Authors:  Bruce L Pihlstrom; Bryan S Michalowicz; Newell W Johnson
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

Review 2.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 3.  New insights into the immunology of chronic obstructive pulmonary disease.

Authors:  Guy G Brusselle; Guy F Joos; Ken R Bracke
Journal:  Lancet       Date:  2011-09-10       Impact factor: 79.321

4.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.

Authors:  Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Cancer Causes Control       Date:  2010-04-17       Impact factor: 2.506

5.  Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection.

Authors:  Dorothy J Wiley; Edward Wiesmeier; Emmanuel Masongsong; Karen H Gylys; Laura A Koutsky; Daron G Ferris; Eliav Barr; Jian Yu Rao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

6.  Cigarette smoking and the desire to quit among individuals living with HIV.

Authors:  Edward M Mamary; Darlene Bahrs; Sharon Martinez
Journal:  AIDS Patient Care STDS       Date:  2002-01       Impact factor: 5.078

7.  Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1(+) smokers with early emphysema.

Authors:  Robert J Kaner; Francisco Santiago; Ronald G Crystal
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

8.  Risk factors for periodontitis in HIV patients.

Authors:  Tamer Alpagot; Nejat Duzgunes; Larry F Wolff; Aaaron Lee
Journal:  J Periodontal Res       Date:  2004-06       Impact factor: 4.419

Review 9.  HIV infection and periodontal diseases: an overview of the post-HAART era.

Authors:  M Mataftsi; L Skoura; D Sakellari
Journal:  Oral Dis       Date:  2010-10-28       Impact factor: 3.511

10.  Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.

Authors:  James M Tesoriero; Susan M Gieryic; Alvaro Carrascal; Howard E Lavigne
Journal:  AIDS Behav       Date:  2010-08
View more
  39 in total

1.  Self-efficacy to quit in HIV-infected smokers.

Authors:  Jonathan Shuter; Alyson B Moadel; Ryung S Kim; Andrea H Weinberger; Cassandra A Stanton
Journal:  Nicotine Tob Res       Date:  2014-08-23       Impact factor: 4.244

2.  Screening for Chronic Obstructive Pulmonary Disease (COPD) in an Urban HIV Clinic: A Pilot Study.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  AIDS Patient Care STDS       Date:  2015-02-27       Impact factor: 5.078

3.  The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.

Authors:  Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare
Journal:  J Neurovirol       Date:  2017-04-20       Impact factor: 2.643

Review 4.  Identifying the appropriate comparison group for HIV-infected individuals.

Authors:  Cherise Wong; Keri Althoff; Stephen J Gange
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

Review 5.  Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis.

Authors:  David M Ledgerwood; Russell Yskes
Journal:  Nicotine Tob Res       Date:  2016-05-31       Impact factor: 4.244

Review 6.  Lung cancer in persons with HIV.

Authors:  Keith Sigel; Alain Makinson; Jonathan Thaler
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

Review 7.  Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV.

Authors:  Lauren R Pacek; Patricia A Cioe
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

8.  Pain self-efficacy, race, and motivation to quit smoking among persons living with HIV (PLWH).

Authors:  Lisa R LaRowe; Yvette Rother; Jessica M Powers; Michael J Zvolensky; Peter A Vanable; Joseph W Ditre
Journal:  Addict Behav       Date:  2020-01-23       Impact factor: 3.913

9.  Cessation-related information, motivation, and behavioral skills in smokers living with HIV.

Authors:  Daniel Shirley; Laura Thibodeau; Sheryl L Catz; Katryna McCoy; Douglas E Jorenby; Nasia Safdar; James M Sosman
Journal:  AIDS Care       Date:  2017-08-17

10.  A randomized, controlled pilot study of warm handoff versus fax referral for hospital-initiated smoking cessation among people living with HIV/AIDS.

Authors:  Laura M Mussulman; Babalola Faseru; Sharon Fitzgerald; Niaman Nazir; Vivek Patel; Kimber P Richter
Journal:  Addict Behav       Date:  2017-11-26       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.